Structure Therapeutics (GPCR) Profit After Tax (2022 - 2026)
Quarterly Profit After Tax fell 62.21% to -$76.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$170.3 million through Mar 2026, down 18.85% year-over-year, with the annual reading at -$141.2 million for FY2025, 15.24% down from the prior year.
Structure Therapeutics' Profit After Tax history spans 5 years, with the latest figure at -$76.0 million for Q1 2026.
- Profit After Tax came in at -$76.0 million for Q1 2026, down from $33.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $33.0 million in Q4 2025 to a low of -$76.0 million in Q1 2026.
- The 5-year median for Profit After Tax is -$24.5 million (2023), against an average of -$28.3 million.
- The largest YoY upside for Profit After Tax was 190.47% in 2025 against a maximum downside of 136.85% in 2025.
- Structure Therapeutics' Profit After Tax stood at -$11.9 million in 2022, then crashed by 106.34% to -$24.5 million in 2023, then crashed by 48.88% to -$36.5 million in 2024, then skyrocketed by 190.47% to $33.0 million in 2025, then crashed by 330.18% to -$76.0 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Profit After Tax are -$76.0 million (Q1 2026), $33.0 million (Q4 2025), and -$65.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -75.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.97 Mn |
| Dec 31, 2025 | 33.00 Mn |
| Sep 30, 2025 | -65.71 Mn |
| Jun 30, 2025 | -61.66 Mn |
| Mar 31, 2025 | -46.83 Mn |
| Dec 31, 2024 | -36.48 Mn |
| Sep 30, 2024 | -33.98 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Mar 31, 2024 | -26.04 Mn |
| Dec 31, 2023 | -24.50 Mn |
| Sep 30, 2023 | -23.86 Mn |
| Jun 30, 2023 | -23.28 Mn |
| Mar 31, 2023 | -17.98 Mn |
| Dec 31, 2022 | -11.88 Mn |
| Sep 30, 2022 | -12.42 Mn |
| Jun 30, 2022 | -13.95 Mn |
| Mar 31, 2022 | -13.08 Mn |